• 1
    Connor SE, Wingate JP. Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy: a survey of current practice amongst radiologists and urologists. Clin Radiol 1999; 54: 598603
  • 2
    Ramey JR, Halpern EJ, Gomella LG. Ultrasonography and biopsy of the prostate. In WeinAJ, KavoussiLR, NovickAC, PartinAW, PetersCA eds, Campbell’s Urology, 9th edn. Philadelphia: Sauders-Elsevier, 2006: 2889
  • 3
    Ihezue CU, Smart J, Dewbury KC, Mehta R, Burgess L. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 2005; 60: 45963
  • 4
    Rajamanickam A, Singh V, Aneja A. When is it appropriate to stop antiplatelet therapy in a patient with a drug-eluting stent prior to noncardiac surgery? IMPACT Consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit. Cleve Clin J Med 2006; 73: (Electronic Suppl;1): S79
  • 5
    Kastrati A, Dibra A, Eberle S et al. Sirolimus-eluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 2005; 294: 81925
  • 6
    Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 212630
  • 7
    Kuchulakanti PK, Chu WW, Torguson R et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 110813
  • 8
    Moreno R, Fernandez C, Hernandez R et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 9549
  • 9
    Ong AT, McFadden EP, Regar E, De Jaegere PP, Van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 208892
  • 10
    Zimarino M, Renda G, De Caterina R. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents. Drugs 2005; 65: 72532
  • 11
    Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47: 21635
  • 12
    Weitz HH. How soon can a patient undergo noncardiac surgery after receiving a drug-eluting stent? Cleve Clin J Med 2005; 72: 81820